$130 Million is the total value of Pivotal bioVenture Partners Investment Advisor LLC's 10 reported holdings in Q2 2024. The portfolio turnover from Q1 2024 to Q2 2024 was 9.1% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
PCVX | VAXCYTE INC | $59,882,148 | +10.5% | 793,036 | 0.0% | 46.04% | +32.2% | |
INZY | INOZYME PHARMA INC | $20,047,035 | -41.8% | 4,494,851 | 0.0% | 15.41% | -30.4% | |
OCULIS HOLDING AGordinary shares | $19,071,220 | -0.8% | 1,595,918 | 0.0% | 14.66% | +18.6% | ||
ARQT | Buy | ARCUTIS BIOTHERAPEUTICS INC | $18,982,304 | -5.5% | 2,041,108 | +0.6% | 14.59% | +13.0% |
EXSCIENTIA PLCads | $3,929,550 | -10.8% | 770,500 | 0.0% | 3.02% | +6.6% | ||
RALLYBIO CORP | $3,222,223 | -27.6% | 2,404,644 | 0.0% | 2.48% | -13.4% | ||
VIGIL NEUROSCIENCE INC | $2,242,380 | +17.3% | 560,595 | 0.0% | 1.72% | +40.3% | ||
BOLT | BOLT BIOTHERAPEUTICS INC | $1,418,600 | -46.4% | 1,891,467 | 0.0% | 1.09% | -35.9% | |
IO BIOTECH INC | $1,011,110 | -32.4% | 864,197 | 0.0% | 0.78% | -19.1% | ||
ALGS | ALIGOS THERAPEUTICS INC | $260,125 | -64.3% | 743,215 | 0.0% | 0.20% | -57.3% | |
FUSN | Exit | FUSION PHARMACEUTICALS INC | $0 | – | -563,385 | -100.0% | -7.72% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-08-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VAXCYTE INC | 15 | Q2 2024 | 46.0% |
INOZYME PHARMA INC | 15 | Q2 2024 | 22.1% |
ARCUTIS BIOTHERAPEUTICS INC | 15 | Q2 2024 | 14.6% |
ALIGOS THERAPEUTICS INC | 15 | Q2 2024 | 8.0% |
BOLT BIOTHERAPEUTICS INC | 14 | Q2 2024 | 20.0% |
FUSION PHARMACEUTICALS INC | 14 | Q1 2024 | 7.7% |
KARUNA THERAPEUTICS INC | 13 | Q4 2023 | 65.4% |
RALLYBIO CORP | 12 | Q2 2024 | 14.1% |
EXSCIENTIA PLC | 11 | Q2 2024 | 6.4% |
VIGIL NEUROSCIENCE INC | 10 | Q2 2024 | 3.0% |
View Pivotal bioVenture Partners Investment Advisor LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-30 |
13F-HR | 2024-08-13 |
13F-HR | 2024-05-14 |
13F-HR | 2024-02-13 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-10 |
13F-HR | 2022-08-12 |
View Pivotal bioVenture Partners Investment Advisor LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.